Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SERKO LIMITED Capital/Financing Update 2018

Dec 20, 2018

65804_rns_2018-12-20_337c5b42-e26f-44cd-9f73-54db24d593e9.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

Appendix 3B New issue announcement

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

New issue announcement, application for quotation of additional securities and agreement

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13

Name of entity

SERKO LIMITED

ABN

ARBN 611 613 980

We (the entity) give ASX the following information.

Part 1 - All issues

You must complete the relevant sections (attach sheets if there is not enough space).

1
+Class of+securities issued or to be
issued
2
Number of+securities issued or to
be issued (if known) or maximum
number which may be issued
3
Principal terms of the+securities
(e.g. if options, exercise price and
expiry
date;
if
partly
paid
+securities, the amount outstanding
and due dates for payment; if
+convertible
securities,
the
conversion price and dates for
conversion)
Options to subscribe for Ordinary Shares in Serko
Limited (Options)
74,632 Options
The majority of Options are exercisable at NZ$2.68
per Option, expiring 20 February 2024. The Options
will vest (meaning they are able to be exercised) in
four tranches commencing two-years after they are
granted, subject to continued employment.
One grant of Options is exercisable at NZ$2.68 per
Option, expiring 20 February 2021. The Options will
vest in a single tranche two years after they are
granted, subject to continued employment.
  • See chapter 19 for defined terms.

Appendix 3B Page 1

04/03/2013

Appendix 3B New issue announcement

4
Do the+securities rank equally in all
respects from the+issue date with an
existing+class of quoted+securities?
If the additional+securities do not rank
equally, please state:
• the date from which they do
• the extent to which they participate for
the next dividend, (in the case of a trust,
distribution) or interest payment
• the extent to which they do not rank
equally, other than in relation to the next
dividend,
distribution
or
interest
payment
5
Issue price or consideration
6
Purpose of the issue
(If
issued
as
consideration
for
the
acquisition of assets, clearly identify those
assets)
6a
Is the entity an+eligible entity that has
obtained security holder approval under rule
7.1A?
If Yes, complete sections 6b – 6h_in relation_
to the+securities the subject of this
Appendix 3B, and comply with section 6i
6b
The date the security holder resolution
under rule 7.1A was passed
6c
Number of
+securities issued without
security holder approval under rule 7.1
6d
Number of+securities issued with security
holder approval under rule 7.1A
6e
Number of+securities issued with security
holder approval under rule 7.3, or another
specific security holder approval (specify
date of meeting)
6f
Number of+securities issued under an
exception in rule 7.2
N/A
Nil.
Grant of Options pursuant to the Serko Limited (US)
2018 Share Incentive Plan as part of the
remuneration package of certain key employees
residing in the United States.
N/A
N/A
N/A
N/A
N/A
N/A
  • See chapter 19 for defined terms.

Appendix 3B Page 2

04/03/2013

Appendix 3B New issue announcement

6g
If+securities issued under rule 7.1A, was
issue price at least 75% of 15 day VWAP as
calculated under rule 7.1A.3? Include the
+issue date and both values. Include the
source of the VWAP calculation.
6h
If+securities were issued under rule 7.1A
for non-cash consideration, state date on
which valuation of consideration was
released to ASX Market Announcements
6i
Calculate the entity’s remaining issue
capacity under rule 7.1 and rule 7.1A –
complete Annexure 1 and release to ASX
Market Announcements
7
+Issue dates
Note: The issue date may be prescribed by ASX (refer to the
definition of issue date in rule 19.12). For example, the issue
date for a pro rata entitlement issue must comply with the
applicable timetable in Appendix 7A.
Cross reference: item 33 of Appendix 3B.
8
Number and+class of all+securities quoted
on ASX (_including_the+securities in section
2 if applicable)
9
Number and+class of all+securities not
quoted on ASX (_including_the+securities in
section 2 if applicable)
10
Dividend policy (in the case of a trust,
distribution policy) on the increased capital
(interests)
N/A N/A
N/A
N/A
20 December 2018
Number +Class
80,922,809 Ordinary Shares
Number +Class
199,263 NZ$2.97 Options. Expiry Date:
6 July 2023
3,521 NZ$2.84 Options
Expiry Date: 30 July 2023
74,632 NZ$2.68 Options. Expiry Date:
2 February 2024 (and 20
February 2021 in one instance)
N/A

Part 2 - Pro rata issue

  • See chapter 19 for defined terms.

Appendix 3B Page 3

04/03/2013

Appendix 3B New issue announcement

11
Is security holder approval required?
12
Is the issue renounceable or non-
renounceable?
13
Ratio in which the+securities will be
offered
14
+Class of+securities to which the offer
relates
15
+Record date to determine entitlements
16
Will holdings on different registers (or
subregisters) be aggregated for calculating
entitlements?
17
Policy for deciding entitlements in
relation to fractions
18
Names of countries in which the entity has
security holders who will not be sent new
offer documents
Note: Security holders must be told how their entitlements
are to be dealt with.
Cross reference: rule 7.7.
19
Closing date for receipt of acceptances or
renunciations
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
  • See chapter 19 for defined terms.

Appendix 3B Page 4

04/03/2013

Appendix 3B New issue announcement

20
Names of any underwriters
21
Amount of any underwriting fee or
commission
22
Names of any brokers to the issue
23
Fee or commission payable to the
broker to the issue
24
Amount of any handling fee payable
to brokers who lodge acceptances or
renunciations on behalf of security
holders
25
If the issue is contingent on security
holders’ approval, the date of the
meeting
26
Date entitlement and acceptance
form and offer documents will be
sent to persons entitled
27
If the entity has issued options, and
the terms entitle option holders to
participate on exercise, the date on
which notices will be sent to option
holders
28
Date rights trading will begin (if
applicable)
29
Date rights trading will end (if
applicable)
30
How do security holders sell their
entitlements_in full_through a
broker?
31
How do security holders sell_part_of
their entitlements through a broker
and accept for the balance?
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
  • See chapter 19 for defined terms.

Appendix 3B Page 5

04/03/2013

Appendix 3B New issue announcement

32 How do security holders dispose of their entitlements (except by sale through a broker)? 33 +Issue date

N/A N/A

Part 3 - Quotation of securities

You need only complete this section if you are applying for quotation of securities

34 Type of[+] securities ( tick one ) (a) +Securities described in Part 1

(b)[All other ][+][securities ]

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

Entities that have ticked box 34(a)

Additional securities forming a new class of securities

Tick to indicate you are providing the information or documents

35 If the[+] securities are[+] equity securities, the names of the 20 largest holders of the additional[+] securities, and the number and percentage of additional[+] securities held by those holders

36 If the[+] securities are[+] equity securities, a distribution schedule of the additional +securities setting out the number of holders in the categories 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001 and over

37 A copy of any trust deed for the additional[+] securities

  • See chapter 19 for defined terms.

Appendix 3B Page 6

04/03/2013

Appendix 3B New issue announcement

Entities that have ticked box 34(b)

38
Number of+securities for which+quotation
is sought
39
+Class of+securities for which quotation is
sought
40
Do the+securities rank equally in all
respects from the+issue date with an
existing+class of quoted+securities?
If the additional+securities do not rank
equally, please state:
• the date from which they do
• the extent to which they participate for
the next dividend, (in the case of a trust,
distribution) or interest payment
• the extent to which they do not rank
equally, other than in relation to the next
dividend,
distribution
or
interest
payment
41
Reason for request for quotation now
Example: In the case of restricted securities, end of restriction
period
(if issued upon conversion of another
+security,
clearly
identify
that
other
+security)
42
Number and+class of all+securities quoted
on ASX (_including_the+securities in clause
38)
Number +Class
  • See chapter 19 for defined terms.

Appendix 3B Page 7

04/03/2013

Appendix 3B New issue announcement

Quotation agreement

  • 1 +Quotation of our additional +securities is in ASX’s absolute discretion. ASX may quote the[+] securities on any conditions it decides.

  • 2 We warrant the following to ASX.

  • The issue of the[+] securities to be quoted complies with the law and is not for an illegal purpose.

  • There is no reason why those[+] securities should not be granted[+] quotation.

  • An offer of the[+] securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

  • Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any[+] securities to be quoted and that no-one has any right to return any[+] securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the +securities be quoted.

  • If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the[+] securities be quoted.

  • 3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

  • 4 We give ASX the information and documents required by this form. If any information or document is not available now, we will give it to ASX before +quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

Sign here: ............................................................ Date: 21 December 2018 (Company secretary)

Print name: ...Susan Putt......................................................

== == == == ==

  • See chapter 19 for defined terms.

Appendix 3B Page 8

04/03/2013